Rockefeller Capital Management L.P. Dexcom Inc Transaction History

Rockefeller Capital Management L.P.

  • $42.4 Billion
  • Q2 2025

A detailed history of Rockefeller Capital Management L.P. transactions in Dexcom Inc stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 10,040 shares of DXCM stock, worth $653,804. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,040
Previous 10,040 -0.0%
Holding current value
$653,804
Previous $876,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
BUY
$59.83 - $87.57 $600,693 - $879,202
10,040 New
10,040 $876,000
Q4 2024

Feb 13, 2025
SELL
$65.68 - $81.01 $189,946 - $234,280
-2,892 Reduced 18.79%
12,502 $972,000
Q3 2024

Nov 14, 2024
SELL
$64.0 - $116.06 $6.42 Million - $11.6 Million
-100,313 Reduced 86.7%
15,394 $1.03 Million
Q2 2024

Aug 12, 2024
SELL
$110.31 - $140.45 $652,152 - $830,340
-5,912 Reduced 4.86%
115,707 $13.1 Million
Q1 2024

May 14, 2024
SELL
$114.22 - $140.1 $1.19 Million - $1.46 Million
-10,441 Reduced 7.91%
121,619 $16.9 Million
Q4 2023

Feb 14, 2024
BUY
$75.49 - $124.16 $192,499 - $316,608
2,550 Added 1.97%
132,060 $16.4 Million
Q3 2023

Nov 14, 2023
BUY
$86.06 - $137.93 $583,228 - $934,751
6,777 Added 5.52%
129,510 $12.1 Million
Q2 2023

Aug 14, 2023
BUY
$112.47 - $130.98 $185,125 - $215,593
1,646 Added 1.36%
122,733 $15.8 Million
Q1 2023

May 17, 2023
BUY
$104.0 - $122.92 $198,120 - $234,162
1,905 Added 1.6%
121,087 $14.1 Million
Q4 2022

Mar 06, 2023
BUY
$84.98 - $122.67 $145,060 - $209,397
1,707 Added 1.45%
119,182 $13.5 Million
Q3 2022

Nov 02, 2022
BUY
$76.35 - $94.18 $59,476 - $73,366
779 Added 0.67%
117,475 $9.46 Million
Q2 2022

Aug 12, 2022
BUY
$67.99 - $132.89 $5.93 Million - $11.6 Million
87,219 Added 295.89%
116,696 $8.7 Million
Q1 2022

May 13, 2022
BUY
$94.08 - $130.2 $40,078 - $55,465
426 Added 1.47%
29,477 $15.1 Million
Q4 2021

Feb 14, 2022
BUY
$129.87 - $162.82 $127,402 - $159,726
981 Added 3.49%
29,051 $15.6 Million
Q3 2021

Nov 12, 2021
BUY
$106.71 - $143.18 $47,485 - $63,715
445 Added 1.61%
28,070 $15.3 Million
Q2 2021

Aug 10, 2021
SELL
$80.99 - $107.93 $45,435 - $60,548
-561 Reduced 1.99%
27,625 $11.8 Million
Q1 2021

May 11, 2021
BUY
$84.79 - $104.74 $154,656 - $191,045
1,824 Added 6.92%
28,186 $10.1 Million
Q4 2020

Feb 12, 2021
SELL
$78.0 - $104.5 $313,326 - $419,776
-4,017 Reduced 13.22%
26,362 $9.75 Million
Q3 2020

Nov 13, 2020
BUY
$95.51 - $112.95 $128,651 - $152,143
1,347 Added 4.64%
30,379 $12.5 Million
Q2 2020

Aug 12, 2020
SELL
$62.68 - $105.34 $228,593 - $384,174
-3,647 Reduced 11.16%
29,032 $11.8 Million
Q1 2020

May 12, 2020
SELL
$47.79 - $75.63 $9.01 Million - $14.3 Million
-188,431 Reduced 85.22%
32,679 $8.8 Million
Q4 2019

Feb 07, 2020
SELL
$36.62 - $57.29 $737,929 - $1.15 Million
-20,151 Reduced 8.35%
221,110 $48.4 Million
Q3 2019

Nov 12, 2019
SELL
$35.53 - $43.8 $3.51 Million - $4.33 Million
-98,838 Reduced 29.06%
241,261 $36 Million
Q2 2019

Aug 09, 2019
BUY
$27.84 - $38.92 $22,522 - $31,486
809 Added 0.24%
340,099 $51 Million
Q1 2019

May 10, 2019
SELL
$28.07 - $38.18 $3.84 Million - $5.23 Million
-136,872 Reduced 28.74%
339,290 $40.4 Million
Q4 2018

Feb 12, 2019
BUY
$26.99 - $37.37 $63,372 - $87,744
2,348 Added 0.5%
476,162 $57 Million
Q3 2018

Nov 02, 2018
SELL
$23.35 - $36.72 $9.81 Million - $15.4 Million
-420,298 Reduced 47.01%
473,814 $67.8 Million
Q2 2018

Jul 31, 2018
SELL
$17.54 - $25.22 $194,781 - $280,068
-11,105 Reduced 1.23%
894,112 $84.9 Million
Q1 2018

May 09, 2018
BUY
$13.06 - $18.54 $11.8 Million - $16.8 Million
905,217 New
905,217 $67.1 Million

Others Institutions Holding DXCM

# of Institutions
1,110
Shares Held
368M
Call Options Held
5.32M
Put Options Held
5.18M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.2B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email